Sign inJoin waitlistJoin the waitlist

Michael Gordon

Physician · HonorHealth

Credentials: · · · ·

History

HonorHealth
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1988–1991
Internal Medicine
University of Chicago Medical Center
1985–1988
Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
1981–1985

Research

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Nature · 2014 · 4,371 citations
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer
Journal of Clinical Oncology · 2001 · First of 9 authors · Corresponding · 785 citations
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Journal of Clinical Oncology · 2016 · 673 citations

DM
David Mendelson
22 papers
Heinz-Josef Lenz
13 papers
JI
Jeffrey Infante
13 papers
HB
Howard Burris
12 papers
JB
Johanna Bendell
12 papers
Sunil Sharma
12 papers
Patricia LoRusso
11 papers
Kim Margolin
10 papers
Michael Atkins
10 papers
Lee Rosen
9 papers
AT
Anthony Tolcher
8 papers
David McDermott
8 papers

Clinical trials

Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
Principal investigator · Terminated · Phase 2
HonorHealth Research Institute
2020–2022